brain tumour

Pedro Mejia: Improving the quality of life of brain tumour patients

23 Aug 2022

Social worker Pedro Mejia describes his work days and how he does his best to support, understand, and reassure patients to help them cope with their disease.

Special Seminar: Intracortical brain computer interfaces

18Feb202115:30
to
16:30

Speaker: David Brandman, MD, PhD, FRCSC, Functional / Stereotactic Neurosurgery Fellow,  Emory University, USA Host: Kevin Petrecca/neuroCategory: Medicine Research MNI

Bridging the gap between AI and the clinic

Published: 30Jan2020

Open source app helps predict brain tumour malignancy and patient survival ...

An infallible hand-held probe to aid cancer surgery

Published: 28Jun2017

Canadian researchers have invented an intraoperative probe that reliably detects multiple types of tumour cells ...

The Neuro’s top brain cancer fundraiser returns

Published: 10Oct2017

A Brilliant Night has donated a total of $1.6 million since 2015...

Cancer probe chosen for top science discovery

Published: 19Mar2018

2017 Québec Science Discovery of the Year Award goes to the cancer-detection probe developed by Kevin Petrecca and Frédéric Leblond...

Brain tumour awareness week

Published: 22Oct2018

Providing excellent care and the latest research to help patients...

Fundraising for those we’ve lost

18 Oct 2019

A Brilliant Night is a way to take action for those impacted by brain cancer

Helping patients manage brain cancer

29 May 2019

The Neuro-Oncology Clinic works with clinical trials team to advance care and research

Pages

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates

 

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

FacebookinstagramtwitterlinkedInyoutube

Back to top